On October 25th, the 3rd China Growth Pharmaceutical Business Development Forum hosted by China Growth Pharmaceuticals Development Forum Organizing Committee and Zhuhai Municipal People's Government, and organized by Jinwan District, etc., with the theme of “Zhuhai win-win”. The cum three-stove biomedical investment promotion conference was held in Dehang Hotel, Zhuhai. At the meeting, 12 pharmaceutical enterprises such as Guangdong Tomson Bekin, Aoga Medical Software, and Tianjin Medical Packaging Materials signed contracts with the Sanzao Town Government, with a total investment of 2.1 billion yuan. It is expected that the total output value of the project will reach 5 billion yuan. Yuan Renminbi.
The disciplinary inspection secretary of the Ministry of Health, Dou Xizhao, deputy secretary of Zhuhai Municipal Committee, mayor Zhong Shijian, and deputy mayor Deng Qunfang attended the opening ceremony of the Medical Forum.
More than 400 drug companies gather together to develop the industry
According to the briefing, the medical forum attracted more than 700 person-in-charges, medical experts, and scholars from more than 400 pharmaceutical companies across the country to gather in Zhuhai to discuss the development of a growing type of pharmaceutical company, and to carry out the future development of the pharmaceutical industry in China. Detailed discussion.
The forum launched entrepreneurial salons, investment promotion, signing ceremony, awards ceremony, gala evening and other events. Fifteen medical heavyweight guests spoke about the future development of pharmaceutical intermediate companies. At the forum, Chinese Academy of Engineering Academician Yao Xinmin, Qin Boyi, and Academician Sun Hanqing of the Chinese Academy of Sciences have successively made "Revealing the Connotation of Traditional Chinese Medicine, Promoting the Modernization of Traditional Chinese Medicine and the Research Process of Innovative Drugs," "The Science and Technology Development Concept Changing Science and Technology Impetuosity," and "Plant Drug Research and Development Thinking." The lecture on "Progress and Progress" was well received by the participants.
It is understood that the two-day medical forum will also take place one day today. Participants will look forward to the future development of medicine and put forward corresponding countermeasures. In this forum, the Guangdong Provincial Department of Economics and Trade awarded Sanzao Town the honorary title of “Guangdong Province Biopharmaceutical Industrial Cluster Upgrade Demonstration Zone”. This is another brilliant achievement of the town after it was awarded “Professional Medicine Town of Guangdong Province” last year.
The pharmaceutical industry gathered to attract many drug companies to settle down
According to reports, Zhuhai has a total of 178 pharmaceutical companies with an annual output value of over 6.1 billion yuan. The municipal government has listed the biomedical industry as one of the six pillar industries in Zhuhai. With the increase of pharmaceutical enterprises and the expansion of industrial scale, the biomedical industry in Zhuhai will face a new round of development opportunities.
In Sanzao Town, there are more than 80 biomedical manufacturing companies and drug management and medical service organizations, and a pharmaceutical industry system integrating medical treatment, medicine, and medical devices has been established. In 2007, the town's bio-pharmaceutical industry output value reached 4.33 billion yuan.
The 12 pharmaceutical companies signed a contract to enter Sanzao. The main products are medicines, health care products, and medical software. They will form a new structure of the pharmaceutical technology industry chain, and greatly enhance the “Sanzao Biomedicine” in the city, the whole province, and even the whole country. The scope of influence provided a powerful guarantee for Sanzao Town to build the largest pharmaceutical industry base in South China.
“Sanzao Town’s pharmaceutical enterprises are relatively concentrated, and the agglomeration effect of the pharmaceutical industry is conducive to the accumulation of pharmaceutical talents and medical resources, and will provide enterprises with vast opportunities for development.” The official in charge of Tomson Health Products told reporters, “Our company has settled in three places. After the stove, it is possible to cooperate with neighboring pharmaceutical companies and seek common development. In addition, there is a medical university in Sanzao Pharmaceutical Industrial Park, which provides a good base for production, research, and research. These are the reasons why we finally chose Sanzao.” The company's Beijian company invested 200 million in three stoves, and its annual production value reached 500 million yuan.
